logo
'Emerging markets no longer on the periphery of progress'

'Emerging markets no longer on the periphery of progress'

Over the past decade, many investors have looked at EM with a mixture of caution and nostalgia, haunted by memories of currency crises and political turmoil. But today's EM landscape looks very different. Structural reform, rising domestic consumption, and tech-led innovation are combining to produce companies and economies that are adaptable and profitable.
This transformation is perhaps best captured by businesses like Kaspi.kz, a 'super-app' used by the majority of the adult Kazak population for everything from banking and bill payments, to shopping and ride-hailing. It has fundamentally reshaped the country's economy. Or take Luckin Coffee in China, which now has many more outlets than Starbucks and continues to grow rapidly into an underpenetrated market. These aren't speculative moonshots. They are scaling in key domestic markets with improving profitability and thus operational resilience.
Two key headwinds - the strong US dollar and negative sentiment towards China - have been turning. An increasing amount of EM-to-EM trade is being done in non-dollar currencies. The weak dollar is not only supportive of EM financial conditions but also creates favourable sentiment at a time when there are plenty of reasons to ask questions of the traditional safe-haven countries of the world. With over $22 trillion held by non-US investors in American assets - much of it unhedged - even a small shift in allocation could drive renewed EM demand.
Meanwhile, China's trajectory is not solely about geopolitics or trade policy, as some doomsayers posit. In fact, this may be the wrong focus completely. It's about a massive, increasingly self-sufficient domestic economy. Retail sales in China are over ten times greater than its exports to the US - a fact that should redirect our focus from tariffs to the consumer. Companies like Meituan and DeepSeek are testament to China's technological resilience. And for what it's worth, over 70% of the world now trades more with China than with the US. On top of this, Chinese consumer spending is visibly starting to recover.
Read more:
We often talk about EM as if it were a single monolith. It is not. What binds these regions is clearly not geography or even income level. But the quality of opportunity and scale of ambition across such a vast set of countries is trending upwards and worth shouting about.
There are many more world class EM companies than before, in a range of industries: in semiconductors, gaming, fintech, and green energy, to name a few. For example, CATL in electric vehicle batteries, SK Hynix in High Bandwith Memory (memory chips used for high-performance computing and AI), and Tencent and SEA in gaming. The best companies earn their place in portfolios through world-class execution, deep competitive moats, high returns on capital, and often, scarcity of competition. EM's best companies are, in many cases, the only game in town for investors seeking exposure to essential themes like electrification, digital transformation, and resource resilience.
Perhaps the most dangerous risk for investors today is underexposure to this transformation. Valuations remain modest. Domestic markets are deepening. Currency, debt, and governance risks - while still present - are far better managed than in previous cycles. And most importantly, these companies are not all reliant on a rebound in global trade or commodity prices. Many are thriving in local ecosystems, with local customers, on local capital.
This is not to say the path ahead is smooth. Politics is messy (though isn't that true in developed markets too?). Markets are often volatile. But the direction of travel is clear. Emerging markets are no longer on the periphery of progress - they are increasingly the protagonists. To ignore them is not caution, it's more likely negligence.
Andrew Keiller is a partner at Baillie Gifford
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Fears over bioethanol plant ‘putting £1.25 billion jet fuel project in jeopardy'
Fears over bioethanol plant ‘putting £1.25 billion jet fuel project in jeopardy'

Leader Live

time22 minutes ago

  • Leader Live

Fears over bioethanol plant ‘putting £1.25 billion jet fuel project in jeopardy'

Crisis talk are ongoing to save Vivergo Fuels, near Hull, following the decision to end the 19% tariff on United States bioethanol imports as part of the recent UK-US trade deal. On Friday, Meld Energy said the situation is putting its plans for a 'world-class' green jet fuel project on the Humber in jeopardy. Earlier this year, Meld Energy signed a £1.25 billion agreement with Vivergo Fuels to anchor a Sustainable Aviation Fuel (SAF) facility at Saltend Chemicals Park in Hull. Meld Energy CEO and founder Chris Smith said: 'We're excited about the potential to bring our sustainable aviation fuel project to the Humber – one of the UK's most important industrial and energy hubs. 'But, for projects like ours to succeed and the flow of vital investment to be forthcoming, we need a strong and integrated low-carbon ecosystem. 'A bioethanol plant on site at Saltend is a critical part of that mix. Without it, we'd have to consider alternative locations overseas where that infrastructure is already in place.' Mr Smith was speaking as the Vivergo plant was expecting its last scheduled wheat delivery from a farm in Lincolnshire on Friday, as the site continues to wind down. Vivergo Fuels managing director Ben Hackett wrote to wheat growers earlier this year explaining that the plant will only be able to honour existing contractual obligations for wheat purchases while uncertainty continues. Mr Hackett said: 'Building a future fuels cluster here in Hull would deliver major economic, environmental and strategic benefits not just for the Humber, but for the whole country. 'We have the site, the skills, the supply chain and the ambition to lead the way on sustainable aviation fuel. 'But, without urgent Government support for British bioethanol, the UK risks losing that opportunity, along with the jobs and billions of pounds in investment that depend on it.' Last month, the firm, which is owned by Associated British Foods (ABF), said it is was beginning consultation with staff to wind down the plant, which employs more than 160 people, due to the uncertain situation – a process which could see production stop before September 13, if support is not provided. It said Britain's two largest bioethanol producers – Vivergo Fuels and Ensus in Teesside – are now in urgent negotiations with the Government. The firms say the UK-US trade deal and regulatory constraints on the industry have made it impossible to compete with heavily subsidised American products. A Government spokesperson said: 'We recognise this is a concerning time for workers and their families which is why we entered into formal discussions with the company on potential financial support last month. 'We will continue to take proactive steps to address the long-standing challenges the company faces and remain committed to working closely with them throughout this period to present a plan for a way forward that protects supply chains, jobs and livelihoods.' The Government said officials and ministers have met with Vivergo and Ensus consistently over the last few months to discuss options to address 'significant challenges' that the bioethanol industry has been facing for some time. It said engagement with the companies 'continues at pace' and external consultants have been brought in to help.

Canada punished as Trump unveils sweeping global tariffs
Canada punished as Trump unveils sweeping global tariffs

Telegraph

time23 minutes ago

  • Telegraph

Canada punished as Trump unveils sweeping global tariffs

Donald Trump has raised tariffs on Canada to 35 per cent, the White House blaming the country's 'illicit drug crisis' for the hike. However, the levy increase comes after Mr Trump warned the country's decision to back a Palestinian state puts a trade deal between the two countries at risk. On Wednesday night, Canada joined the UK in announcing that it would recognise a Palestinian state at the United Nations in September. Following the announcement, Mr Trump said it would be 'very hard' for the US and Canada to strike a deal. Mr Trump later added that he did not view the move as 'a deal breaker' in trade talks, however. The tariff increase from 25 per cent to 35 per cent was a result of Canada's fentanyl crisis and its 'continued inaction and retaliation', the White House said. Mr Trump had earlier told reporters that Canadian Prime Minister Mark Carney had called ahead of an August 1 tariff deadline, however, a conversation between the two did not take place. Any country that fails to strike a deal with the US before Friday would be subjected to higher levies, Mr Trump said. 'We haven't spoken to Canada today. (Carney) called and we'll, we'll see,' Mr Trump said during an event at the White House before the 35 per cent rate was announced. Mr Carney is yet to release a statement. The Canadian leader previously said trade talks with Washington had been constructive, but that they may not conclude before the deadline. Talks between the two countries were at an intense phase, he added, but a deal that would remove all US tariffs was unlikely. 'Well, they have to pay a fair rate - that's all. It's very simple. They have been charging very, very high tariffs to our farmers, some over 200 per cent and they've been treating our farmers very badly,' Mr Trump said, when asked about negotiations. He added that while he loves Canada, it has treated the United States 'very badly' for years.

Trump accuses foreign nations of ‘freeloading' on drug prices as Australia insists PBS prices won't rise
Trump accuses foreign nations of ‘freeloading' on drug prices as Australia insists PBS prices won't rise

The Guardian

time23 minutes ago

  • The Guardian

Trump accuses foreign nations of ‘freeloading' on drug prices as Australia insists PBS prices won't rise

Donald Trump has threatened a crackdown on major pharmaceutical companies who fail to sell cheaper drugs to the US, and criticised nations 'freeloading on US innovation'. Trump wrote to 17 pharmaceutical companies, demanding they treat the US as the 'most favoured nation' and lower prices of drugs for the US Medicaid scheme, and threatened to use 'every tool in our arsenal' to crack down on pharmaceutical giants if they fail to cut drug prices for Americans within 60 days. In Australia, under the pharmaceutical benefits scheme (PBS), pharmaceutical companies negotiate directly with the department of health on pricing. The Australian government hasn't said whether tariffs or restrictions from the US on pharmaceuticals would impact the PBS. Pharmaceuticals are already covered under Australia's existing free trade agreement with the US. Medicines on the PBS are capped for the public, with the government subsidising the rest of the cost. The government recently announced another drop in the price of prescriptions within the scheme, to $25 per script from 1 January. 'The PBS is not up for negotiation,' a government spokesperson said. 'Our government is getting on with the job of delivering cheaper medicines for Australians.' Labor has said repeatedly that prices wouldn't rise in Australia. Health minister Mark Butler said on Tuesday the US administration had been changing its position 'a lot' on pharmaceuticals. 'It's still shifting around a bit. I think it's fair to say our officials are working hard to get a sense exactly of the nature and the timing of any tariffs on pharmaceutical exports,' he told ABC radio. 'Which … is a particular sector or industry that the US administration has been focused on.' The US pharmaceutical lobby has complained to the Trump administration that the PBS undervalues drugs, and have criticised the long lead time for drug approvals in Australia. Trump has also threatened countries globally to increase baseline tariffs to 15 or 20%. The administration's latest tariff deadline was recently delayed to 1 August. Trump has said countries that didn't negotiate a trade deal directly with the US before that deadline – which was set to come into effect on Friday afternoon, Australian time – could face new levies. On Friday morning in Australia, Trump issued an executive order confirming new tariff deals for several trading partners, as well as revised tariffs for a number of other countries. Australian goods imported into the US will continue to attract the baseline 10% tariff, under the new tariff regime which will take effect in seven days. In the executive order, Trump indicated he was open to further negotiations on tariffs for countries he saw as in accordance with his America First agenda. The opposition has heavily criticised the prime minister for not having sat down with Trump for a meeting since he was elected president. The two were supposed to meet on the sidelines of the G7 Summit in Canada in June, but the president left early after an escalation in tensions in the Middle East.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store